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A commentary on
Memory reconsolidation, emotional
arousal and the process of change in
psychotherapy: new insights from brain
science
by Lane, R., Ryan, L. R., Nadel, L., and
Greenberg, L. (2014). Behav. Brain Sci.
1–80. doi: 10.1017/S0140525X14000041
Based on an extant literature review Lane
et al. propose that therapeutic success
results from changing conflictual, often
non-conscious, emotional memories.
Specifically, existent internal autobi-
ographical models based on negative
emotional memories become activated
within the context of a positively colored
therapeutic dyad and are reconsolidated
as new, more positively colored internal
models. Based on empirical evidence, we
would like to extend this model by describ-
ing how the reconsolidation process may
be facilitated on at least three levels of
neurobiological functioning. Those three
levels relate to an overarching principle in
the function of the neuropeptide oxytocin
to facilitate the construction and selec-
tion of positive internal models of social
relationships and support.
First, oxytocin facilitates social bonds
and trust as well as counteracts stress by
dampening activity of physiological stress-
systems and increasing parasympathic
activity, and regulates glucocorticoid
receptor expression in the hippocam-
pus (Carter, 1998, see also Quirin et al.,
2011). As such, oxytocin might facilitate
the establishment of a positive therapeutic
alliance and a relaxed atmosphere during
therapy, which makes it easier for patients
to awaken conflictual memories and tol-
erate concomitantly resurfacing negative
emotions.
Second, oxytocin is implicated in the
ontogenetic development of the neocor-
tex and thus plays an important role
in the construction of internal models
(Carter, 2014). For example, it stimulates
genetic regulation of the growth of the
neocortex and the maintenance of the
blood supply to the cortex—conditions
that are prerequisites for the formation
and sustentation of internal autobiograph-
ical models. In humans, oxytocin also
facilitates cognitive control that helps indi-
viduals to bring behavior in line with
internal models (Tops et al., 2013a). This
is important since behavior control is a
highly valued aspect of therapeutic suc-
cess, which remained unaddressed by Lane
and colleagues.
Third, oxytocin unfolds effects on
a higher level of brain functioning.
Specifically, while increasing familiarity
and trust within a social context, oxytocin
promotes the assimilation of novel emo-
tional experiences into internal models
(e.g., Tops et al., 2013b; for a review, see
Tops et al., 2013a). This process takes place
on the basis of semantic elaboration and
verbalization of emotions as supported
by parts of the left inferior frontal gyrus
(Tops et al., 2014). This is compatible with
the model by Lane et al., according to
which the ability to symbolize and explain
traumatic emotional memories in words
helps individuals assimilate these memo-
ries into their narrative internal models of
themselves and the world.
Based on these findings, oxytocinergic
interventions may be developed to unfold
their potential to facilitate therapeutic
change (Harris and Carter, 2013). Such
interventions may be especially helpful for
so-called alexithymic patients, that is, indi-
viduals suffering difficulties in becoming
aware of and in verbalizing their emotions
(Taylor and Bagby, 2004). In fact, initial
evidence indicates that intranasal oxytocin
application increases verbal emotional
sharing (Lane et al., 2013) and, especially
in alexithymic patients, emotion recogni-
tion (Luminet et al., 2011). This is of high
importance since alexithymia is increased
in a broad array of mental disorders such
as depression, anxiety, posttraumatic stress
disorder, schizophrenia and autism spec-
trum disorder, and predicts poor therapy
outcome (Samur et al., 2013). Moreover,
in autism spectrum disorder patients, defi-
ciencies that were found to be reduced
after intranasal oxytocin application, such
as decreased eye-fixation, relate to alex-
ithymia scores but not to autism symp-
toms, suggesting that it may be alexithymic
deficiencies that are reduced by oxytocin
(Bird et al., 2011).
Characteristics such as alexithymia may
not only relate to larger oxytocin-induced
improvements in emotion recognition and
perception skills, but also to aversive
responses to those improvements because
they hinder habitual defenses in those
individuals. Results suggest that affilia-
tive effects of oxytocin might be lim-
ited to situations in which the subject
already feels a sense of social inclu-
sion (De Dreu, 2012) or more generally,
when interaction partners are familiar or
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when there is opportunity to familiar-
ize oneself with interaction partners (Tops
et al., 2013a,b, 2014). Oxytocin facilitates
the perception of positive and support-
ive social cues (Theodoridou et al., 2009;
Guastella and MacLeod, 2012) allowing
for positive familiarization and habitua-
tion of social uneasiness (“familiarization-
habituation response;” Tops et al., 2013b).
Alexithymia, as well as fearful attach-
ment and self-criticism, are associated
with negative responses to and avoidance
of positive social cues (Dewitte and De
Houwer, 2008; Gilbert et al., 2012). In
a study of borderline personality disor-
der patients and healthy controls, fear-
ful attachment mediated decreased trust
and cooperation after intranasal oxytocin
(Bartz et al., 2011a). Similarly, non-clinical
participants higher in self-criticism, and
those lower in attachment security, had
less positive experiences of compassion-
focused imagery after intranasal oxytocin
than placebo (Rockliff et al., 2011)1. This
suggests that facilitation of the percep-
tion of positive and supportive cues by
oxytocin may be aversive for individuals
who defensively prefer to avoid such cues
to prevent painful experiences of loosing
love and support (Gilbert et al., 2012).
Potential aversive responses to oxytocin
treatment means that further research
is needed regarding the suitability and
optimal strategies of oxytocin treatment
to facilitate therapy in specific target
groups.
In summary, oxytocin might act as a
facilitator or even mediator for the ther-
apeutic effects described by the authors
of the target article: Since oxytocin facil-
itates both the establishment of posi-
tive, trustful relationships and the assim-
ilation of emotional information into
internal models, it may constitute a
central neurobiological promoter of the
1In this double-blind randomized within-subject
study all subjects took part in an identical placebo
and oxytocin treatment session. Interestingly, if the
samples were split according to high and low self-
criticism score, effects were only present for high
self-critics who showed significantly more resistance
to compassion-focused imagery when given oxytocin
first. This suggests that intranasal oxytocin may have
amplified perception of positive and supportive social
cues in the novel social context of the first session,
reflecting amplification of oxytocin’s natural func-
tion in familiarization-habituation responses (Tops
et al., 2013b). In turn, perception of supportive posi-
tive social cues increases resistance in high self-critical
individuals.
reconsolidation of adverse or even trau-
matic memories within the context of psy-
chotherapy. However, personality traits,
disorder severity, context, and potentially
other factors may moderate effects of oxy-
tocin on psychosocial functioning (Bartz
et al., 2011b) and have to be taken
into account when thinking about how
to implement oxytocinergic interventions.
Moreover, individuals who normally avoid
or react aversively to positive and sup-
portive social cues need special attention
in the context of therapy and oxytocin
augmentation.
REFERENCES
Bartz, J. A., Zaki, J., and Bolger, N., and Ochsner, K.
N. (2011b). Social effects of oxytocin in humans:
context and person matter. Trends Cogn. Sci. 15,
301–309. doi: 10.1016/j.tics.2011.05.002
Bartz, J., Simeon, D., Hamilton, H., Kim, S., Crystal,
S., Braun, A., et al. (2011a). Oxytocin can hin-
der trust and cooperation in borderline personality
disorder. Soc. Cogn. Affect. Neurosci. 6, 556–563.
doi: 10.1093/scan/nsq085
Bird, G., Press, C., and Richardson, D. C. (2011).
The role of alexithymia in reduced eye-fixation
in autism spectrum conditions. J. Autism Dev.
Disord. 41, 1556–1564. doi: 10.1007/s10803-011-
1183-3
Carter, C. S. (1998). Neuroendocrine per-
spectives on social attachment and love.
Psychoneuroendocrinology 23, 779–818. doi:
10.1016/S0306-4530(98)00055-9
Carter, C. S. (2014). Oxytocin pathways and the evo-
lution of human behavior. Annu. Rev. Psychol.
65, 17–39. doi: 10.1146/annurev-psych-010213-
115110
De Dreu, C. K. (2012). Oxytocin modulates
cooperation within and competition between
groups: an integrative review and research
agenda. Horm. Behav. 61, 419–428. doi:
10.1016/j.yhbeh.2011.12.009
Dewitte, M., and De Houwer, J. (2008). Adult attach-
ment and attention to positive and negative
emotional face expressions. J. Res. Pers. 42,
498–505. doi: 10.1016/j.jrp.2007.07.010
Gilbert, P., McEwan, K., Gibbons, L., Chotai, S.,
Duarte, J., and Matos, M. (2012). Fears of
compassion and happiness in relation to alex-
ithymia, mindfulness, and self-criticism. Psychol.
Psychother. 85, 374–390. doi: 10.1111/j.2044-
8341.2011.02046.x
Guastella, A. J., and MacLeod, C. (2012). A crit-
ical review of the influence of oxytocin nasal
spray on social cognition in humans: evidence and
future directions. Horm. Behav. 61, 410–418. doi:
10.1016/j.yhbeh.2012.01.002
Harris, J. C., and Carter, C. S. (2013). Therapeutic
interventions with oxytocin: current status and
concerns. J. Am. Acad. Child Adolesc. Psychiatry 52,
998–1000. doi: 10.1016/j.jaac.2013.08.001
Lane, A., Luminet, O., Rimé, B., Gross, J. J.,
de Timary, P., and Mikolajczak, M. (2013).
Oxytocin increases willingness to socially share
one’s emotions. Int. J. Psychol. 48, 676–681. doi:
10.1080/00207594.2012.677540
Luminet, O., Grynberg, D., Ruzette, N., and
Mikolajczak, M. (2011). Personality-dependent
effects of oxytocin: greater social benefits for high
alexithymia scorers. Biol. Psychol. 87, 401–406.
doi: 10.1016/j.biopsycho.2011.05.005
Quirin, M., Kuhl, J., and Düsing, R. (2011). Oxytocin
buffers cortisol responses to stress in individ-
uals with impaired emotion regulation abili-
ties. Psychoneuroendocrinology 36, 898–904. doi:
10.1016/j.psyneuen.2010.12.005
Rockliff, H., Karl, A., McEwan, K., Gilbert, J., Matos,
M., and Gilbert, P. (2011). Effects of intranasal
oxytocin on ‘compassion focused imagery.’
Emotion 11, 1388–1396. doi: 10.1037/a0023861
Samur, D., Tops, M., Schlinkert, C., Quirin, M.,
Cuijpers, P., and Koole, S. L. (2013). Four
decades of research on alexithymia: moving toward
clinical applications. Front. Psychol. 4:861. doi:
10.3389/fpsyg.2013.00861
Taylor, G. J., and Bagby, R. M. (2004). New trends
in alexithymia research. Psychother. Psychosom. 73,
68–77. doi: 10.1159/000075537
Theodoridou, A., Rowe, A. C., Penton-Voak, I. S.,
and Rogers, P. J. (2009). Oxytocin and social per-
ception: oxytocin increases perceived facial trust-
worthiness and attractiveness. Horm. Behav. 56,
128–132. doi: 10.1016/j.yhbeh.2009.03.019
Tops, M., Buisman-Pijlman, F. T. A., and Carter,
C. S. (2013a). “Oxytocin and attachment facil-
itate a shift from seeking novelty to recog-
nizing and preferring familiarity: the key to
increasing resilience?” in The Resilience Handbook:
Approaches to Stress and Trauma, eds M. Kent, M.
C. Davis, and J. W. Reich (London, UK: Routledge
Publishers), 115–130.
Tops, M., Huffmeijer, R., Linting, M., Grewen, K.
M., Light, K. C., Koole, S. L., et al. (2013b).
The role of oxytocin in familiarization-habituation
responses to social novelty. Front. Psychol. 4:761.
doi: 10.3389/fpsyg.2013.00761
Tops, M., Koole, S. L., IJzerman, H., and Buisman-
Pijlman, F. T. A. (2014). Why social attachment
and oxytocin protect against addiction and stress:
insights from the dynamics between ventral and
dorsal corticostriatal systems. Pharmacol. Biochem.
Behav. 119, 39–48. doi: 10.1016/j.pbb.2013.07.015
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 11 August 2014; accepted: 06 September 2014;
published online: 23 September 2014.
Citation: Quirin M, Carter CS, Bode RC, Düsing R,
Radtke EL and Tops M (2014) The role of oxytocin and
alexithymia in the therapeutic process. Front. Psychol.
5:1074. doi: 10.3389/fpsyg.2014.01074
This article was submitted to Emotion Science, a section
of the journal Frontiers in Psychology.
Copyright © 2014 Quirin, Carter, Bode, Düsing,
Radtke and Tops. This is an open-access article dis-
tributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the
original publication in this journal is cited, in accor-
dance with accepted academic practice. No use, distribu-
tion or reproduction is permitted which does not comply
with these terms.
Frontiers in Psychology | Emotion Science September 2014 | Volume 5 | Article 1074 | 2
